These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Lorcaserin and adiposopathy: 5-HT2c agonism as a treatment for 'sick fat' and metabolic disease. Bays HE Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1429-45. PubMed ID: 19900026 [TBL] [Abstract][Full Text] [Related]
8. Rational design of a combination medication for the treatment of obesity. Greenway FL; Whitehouse MJ; Guttadauria M; Anderson JW; Atkinson RL; Fujioka K; Gadde KM; Gupta AK; O'Neil P; Schumacher D; Smith D; Dunayevich E; Tollefson GD; Weber E; Cowley MA Obesity (Silver Spring); 2009 Jan; 17(1):30-9. PubMed ID: 18997675 [TBL] [Abstract][Full Text] [Related]
9. Challenges in the discovery and development of new agents for the treatment of obesity. Staten MA Clin Pharmacol Ther; 2007 May; 81(5):753-5. PubMed ID: 17377527 [TBL] [Abstract][Full Text] [Related]
10. The obesity pipeline: current strategies in the development of anti-obesity drugs. Cooke D; Bloom S Nat Rev Drug Discov; 2006 Nov; 5(11):919-31. PubMed ID: 17080028 [TBL] [Abstract][Full Text] [Related]
12. Medical therapy for obesity--current status and future hopes. Bray GA Med Clin North Am; 2007 Nov; 91(6):1225-53, xi. PubMed ID: 17964918 [TBL] [Abstract][Full Text] [Related]
13. Behavior therapy for obesity: where are we now? Sarwer DB; von Sydow Green A; Vetter ML; Wadden TA Curr Opin Endocrinol Diabetes Obes; 2009 Oct; 16(5):347-52. PubMed ID: 19623061 [TBL] [Abstract][Full Text] [Related]
14. Medical versus surgical interventions for the metabolic complications of obesity in children. Dixon JB; Jones K; Dixon M Semin Pediatr Surg; 2009 Aug; 18(3):168-75. PubMed ID: 19573759 [TBL] [Abstract][Full Text] [Related]
15. Clinical trial success rates of anti-obesity agents: the importance of combination therapies. Hussain HT; Parker JL; Sharma AM Obes Rev; 2015 Sep; 16(9):707-14. PubMed ID: 26222385 [TBL] [Abstract][Full Text] [Related]
16. Medications for weight reduction. Bray GA Endocrinol Metab Clin North Am; 2008 Dec; 37(4):923-42. PubMed ID: 19026940 [TBL] [Abstract][Full Text] [Related]
17. A review of late-stage CNS drug candidates for the treatment of obesity. Heal DJ; Gosden J; Smith SL Int J Obes (Lond); 2013 Jan; 37(1):107-17. PubMed ID: 22410963 [TBL] [Abstract][Full Text] [Related]
18. Targeting hyperglycaemia with anti-obesity drugs: time for a paradigm shift? Krentz AJ; Hompesch M Drugs; 2013 Oct; 73(15):1649-51. PubMed ID: 24092613 [No Abstract] [Full Text] [Related]
19. Dirlotapide: a review of its properties and role in the management of obesity in dogs. Wren JA; Gossellin J; Sunderland SJ J Vet Pharmacol Ther; 2007 Aug; 30 Suppl 1():11-6. PubMed ID: 17567510 [TBL] [Abstract][Full Text] [Related]
20. Plants popularly used for loosing weight purposes in Porto Alegre, South Brazil. Dickel ML; Rates SM; Ritter MR J Ethnopharmacol; 2007 Jan; 109(1):60-71. PubMed ID: 16963210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]